3 global pharma giants, NUS and A*Star team up for manufacturing innovation
[SINGAPORE] Pharmaceutical manufacturing in Singapore is set to benefit from industry partnerships, with Minister for Trade and Industry (Industry) S Iswaran announcing the launch on Tuesday of the Pharma Innovation Programme Singapore.
The industry development scheme is a tie-up between the National University of Singapore, the Agency for Science, Technology and Research (A*Star) and three global drug giants - GlaxoSmithKline, Pfizer and MSD.
It will focus on areas such as continuous manufacturing, bio-catalysis, process analytical technology and advanced process control.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Sony deal for Paramount would draw added regulatory scrutiny
Lululemon to shutter Washington distribution center, lay off 128 employees
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece
P&G raises annual core profit forecast on resilient demand, price hikes
Cordlife calls for trading halt after shares sink to all-time low, pending announcement
Marina Bay Sands Q1 profit surges 51.5% to US$597 million on tourism boom